Search | OpenScholar

Search results

1498 results found

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

Publication: Journal Article

Brin, MF, CL Comella, J Jankovic, F Lai, M Naumann, and BoNTA Study Group. 2008. “Long-Term Treatment With Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay.”. Mov Disord.

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

Publication: Journal Article

Kordower, JH, Y Chu, RA Hauser, CW Olanow, and TB Freeman. 2008. “Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report”. Mov Disord.

Pregabalin (Lyrica) in the treatment of Essential Tremor.

Publication: Journal Article

Zesiewicz, TA, CL Ward, RA Hauser, JA Pease Campbell, and KL Sullivan. 2007. “Pregabalin (Lyrica) in the Treatment of Essential Tremor.”. Movement Disorders.

Duodenal levodopa infusion for the treatment of Parkinson’s disease.

Publication: Journal Article

Samanta, J, and RA Hauser. 2007. “Duodenal Levodopa Infusion for the Treatment of Parkinson’s Disease.”. Expert Opinion Pharmacother.

Advances in the pharmacologic management of early Parkinson’s Disease.

Publication: Journal Article

Hauser, RA, and TA Zesiewicz. 2007. “Advances in the Pharmacologic Management of Early Parkinson’s Disease.”. Neurologist.

Levodopa/carbidopa/entacapone in Parkinson's disease. Expert Rev Neurother

Publication: Journal Article

Seeberger, LC, and RA Hauser. 2009. “Levodopa/Carbidopa/Entacapone in Parkinson’s Disease. Expert Rev Neurother”. Expert Rev Neurother.

Sleep disorders in Parkinson’s disease.

Publication: Journal Article

Jahan, I, RA Hauser, KL Sullivan, A Miller, and TA Zesiewicz. 2009. “Sleep Disorders in Parkinson’s Disease.”. Neuropsychiatr Dis Treat.

GCH1 in early-onset Parkinson's disease.

Publication: Journal Article

Cobb, SA, C Wider, OA Ross, IF Mata, CH Adler, A Rajput, AH Rajput, et al. 2009. “GCH1 in Early-Onset Parkinson’s Disease.”. Mov Disord.

Adenosine, adenosine A2A antagonists, and Parkinson's disease.

Publication: Journal Article

Jenner, P, A Mori, RA Hauser, M Morelli, BB Fredholm, and JF Chen. 2009. “Adenosine, Adenosine A2A Antagonists, and Parkinson’s Disease.”. Parkinsonism Relat Disord.

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease

Publication: Journal Article

Kordower, JH, Y Chu, RA Hauser, TB Freeman, and CW Olanow. 2008. “Lewy Body-Like Pathology in Long-Term Embryonic Nigral Transplants in Parkinson’s Disease”. Nat Med.